Skip to content
52
For organizationsPricingSign in

Connections

Alliance for Biopharmaceutical Competitiveness and Innovation

15 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to

Alliance for Biopharmaceutical Competitiveness and Innovation

Federal lobbying records

Open page
Bills it lobbied on8 of 11
HR 1347 AIMM Act4 reports · In committeeHR 574 ALIGN Act4 reports · In committeeS 187 ALIGN Act4 reports · In committeeHR 1990 American Innovation and R&D Competitiveness Act of 20254 reports · In committeeHR 1062 Growing and Preserving Innovation in America Act of 20254 reports · In committeeS 559 AIMM Act4 reports · In committeeHR 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 143 reports · Became lawS 2021 Close the Round-Tripping Loophole Act3 reports · In committee
Lawmakers it funded or lobbied7 of 10
Jodey ArringtonLeads 2 of these billsAdrian SmithLeads 1 of these billsJames LankfordLeads 1 of these billsRandy FeenstraLeads 1 of these billsRon EstesLeads 1 of these billsRon WydenLeads 1 of these billsShelley CapitoLeads 1 of these bills
Alliance for Biopharmaceutical Competitiveness and Innovation: 8 of 11 bills it lobbied on and 7 of 10 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of Alliance for Biopharmaceutical Competitiveness and Innovation
HR 1347Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named HR 1347, “AIMM Act”, in 4 lobbying reports.4 reports
HR 574Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named HR 574, “ALIGN Act”, in 4 lobbying reports.4 reports
S 187Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named S 187, “ALIGN Act”, in 4 lobbying reports.4 reports
HR 1990Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named HR 1990, “American Innovation and R&D Competitiveness Act of 2025”, in 4 lobbying reports.4 reports
HR 1062Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named HR 1062, “Growing and Preserving Innovation in America Act of 2025”, in 4 lobbying reports.4 reports
S 559Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named S 559, “AIMM Act”, in 4 lobbying reports.4 reports
HR 1Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 3 lobbying reports.3 reports
S 2021Bills it lobbied onAlliance for Biopharmaceutical Competitiveness and Innovation named S 2021, “Close the Round-Tripping Loophole Act”, in 3 lobbying reports.3 reports
Jodey ArringtonLawmakers it funded or lobbiedJodey Arrington leads 2 bills Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 2 of these bills
Adrian SmithLawmakers it funded or lobbiedAdrian Smith leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills
James LankfordLawmakers it funded or lobbiedJames Lankford leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills
Randy FeenstraLawmakers it funded or lobbiedRandy Feenstra leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills
Ron EstesLawmakers it funded or lobbiedRon Estes leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills
Ron WydenLawmakers it funded or lobbiedRon Wyden leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills
Shelley CapitoLawmakers it funded or lobbiedShelley Capito leads 1 bill Alliance for Biopharmaceutical Competitiveness and Innovation lobbied on.Leads 1 of these bills